Innovative Healthcare (002173.SZ) participating company Quanxin Medicine plans to promote the B+ round of financing

Zhitong Finance App News, Innovative Healthcare (002173.SZ) announced that due to business development needs, the company's participating company Quanjing Medical has decided to accept investments from Puhua SME Phase II (Hangzhou) Venture Capital Partnership (limited partnership) (“Puhua Middle and Small”), Changzhou Hengnuo Digital Smart Venture Capital Partnership (limited partnership) (“Changzhou Hengnuo”), and Hangzhou High-Level Talent Innovation and Entrepreneurship Investment Partnership (Limited Partnership) (“Talent Fund”).

Recently, the board of directors of the company reviewed and passed the “Proposal on Agreeing to Sign the “B+ Round Capital Increase Agreement” and “B+ Round Shareholder Agreement” and related documents for participating companies. According to Quanjing Medicine's “B+ Round Capital Increase Agreement”, the current capital increase plan is: Puhua Middle School invested 20 million yuan in monetary form and pledged the additional registered capital of 118.05.79 million yuan in the B+ round; Changzhou Hengnuo invested 5 million yuan in monetary form to pledge Quan Medical's additional registered capital of 2951.45 million yuan in the B+ round; and the Talent Fund invested 5 million yuan in monetary form. The registered capital of Holistic Medicine increased to 165.281.06 million yuan. PricewaterhouseCoopers, Changzhou Hengnuo, and the Talent Fund each obtained 7.1429%, 1.7857%, and 1.7857% of Quanxin Medical's shares after this capital increase. After the implementation of this capital increase and share transfer plan, Quanjing Medicine's share of the company's investment amount was 16.5160%.